Wed, 19 July 2017
After Puma Biotech's recent success, the search is on for other clinical-stage biotech stocks being run by proven CEOs. Could experience turn Aurinia Pharmaceuticals, Axovant Sciences, and Esperion Therapeutics into winners too? Thanks to Slack for supporting Motley Fool. Learn more at slack.com.
|
Tue, 18 July 2017
We field Foolish questions from the world of consumer and retail. First, Levi wants to know about the prospects for apparel retailer Buckle (and its double-digit dividend yield). Meanwhile, Shubhra is curious about Kirkland Signature and why the Costco private label is available on Amazon.com.
Thanks to Harry’s for supporting Industry Focus. Get your Free Trial Set -- go to Harrys.com/fool. |
Mon, 17 July 2017
Brian Patrick Eha, author of How Money Got Free, joins Gaby Lapera to discuss cryptocurrencies, tokens, blockchain technology, and what it all means for investors, regulators, and financial systems. Thanks to Slack for supporting Motley Fool. Learn more at slack.com. |
Fri, 14 July 2017
We love covering IPOs, but we can't bring ourselves to buy a stock that's only been publicly traded for a few months. We explain why on the final episode of "never will I ever week." |
Thu, 13 July 2017
We all make investing mistakes, but buying a commodity producer lacking a cost advantage shouldn’t be one of them. |
Wed, 12 July 2017
Only 10% of drugs make it across the FDA finish line from phase 1 clinical trials, making acquiring pre-clinical biotech stocks the riskiest game in town. |
Tue, 11 July 2017
We continue with our theme for this week, as Asit Sharma explains the major hurdles day traders and speculators face in their pursuit of easy profits. |
Mon, 10 July 2017
In this episode of Industry Focus: Financials, we dig into things we'd never do -- or, at least, that we try to avoid. This includes investing advice, as well as pointers about life more generally. |
Fri, 7 July 2017
Looking for a beach read or a podcast to pass the time on the family trip? We run through some of our favorite tech books and shows so you can still get your fix during the slow months of summer.
|
Thu, 6 July 2017
Energy: Why Exxon Mobil Paid $5.6 billion to 1 of US’s Richest Families to Expand Its Permian Shale Presence
Is being late better than never arriving for America's biggest oil major? |